OCDOVIZPriority claimed from 17/06/2022; Application No. : 97/463214 ;United States of America (Class 5)
#5724862
Application Number:5724862
Status:
Unknown
Class:5
Applicant: JOHNSON & JOHNSON
Filing Date:Fri, 16 Dec 2022
Get a free email alert the moment this application's status changes.
Trademark Information
| Trademark | OCDOVIZPriority claimed from 17/06/2022; Application No. : 97/463214 ;United States of America |
| Trademark Type | Wordmark |
| Class | 5 |
| Application Number | 5724862 |
| Nature/Scope of business | Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; anti-allergics; vaccines. |
| Publication | In Journal No. 2109 |
| Status | Unknown |
| Applicant: | JOHNSON & JOHNSON |
| Applicant Address | One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933, United States of America A corporation organized and existing under the laws of the State of New Jersey |
| Jurisdiction | DELHI |
| Agent | LALL & SETHI |
| Agent Address | D-17, South Extension Part II, New Delhi 110049, India |
Frequently Asked Questions
Who is the owner of trademark OCDOVIZPriority claimed from 17/06/2022; Application No. : 97/463214 ;United States of America? ▾
The trademark application number 5724862 is owned by JOHNSON & JOHNSON.
Which class does trademark OCDOVIZPriority claimed from 17/06/2022; Application No. : 97/463214 ;United States of America belong to? ▾
Trademark application number 5724862 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 5724862? ▾
The trademark agent associated with application number 5724862 is LALL & SETHI.
Was trademark OCDOVIZPriority claimed from 17/06/2022; Application No. : 97/463214 ;United States of America published in the journal? ▾
Yes, trademark application number 5724862 was published in Journal No. 2109.
What is trademark OCDOVIZPriority claimed from 17/06/2022; Application No. : 97/463214 ;United States of America? ▾
Trademark application number 5724862 relates to "Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; anti-allergics; vaccines.".
File Trademark at Just ₹1,499 + Govt Fees
Get your trademark registered with expert guidance. Limited time offer!
File NowExpert Consultation
Quick Processing
100% Support
Free Report
Get Detailed Trademark Report
Comprehensive analysis of your trademark search delivered to your phone
What you'll get:
- Complete trademark analysis
- Conflict assessment
- Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified